Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

[Efficacy, safety and tolerability of high-dose topiramate with rapid dose titration in symptomatic West syndrome].

Kumada T, Miyajima T, Oda N, Shimomura H, Saito K, Hiejima I, Nozaki F, Fujii T.

No To Hattatsu. 2012 Nov;44(6):455-9. Japanese.

PMID:
23240526
2.

Topiramate for the treatment of infantile spasms.

Hosain SA, Merchant S, Solomon GE, Chutorian A.

J Child Neurol. 2006 Jan;21(1):17-9.

PMID:
16551447
3.

Topiramate slow dose titration: improved efficacy and tolerability.

Albsoul-Younes AM, Salem HA, Ajlouni SF, Al-Safi SA.

Pediatr Neurol. 2004 Nov;31(5):349-52.

PMID:
15519117
4.

Topiramate monotherapy in infantile spasm.

Kwon YS, Jun YH, Hong YJ, Son BK.

Yonsei Med J. 2006 Aug 31;47(4):498-504.

5.

Topiramate in children with west syndrome: a retrospective multicenter evaluation of 100 patients.

Korinthenberg R, Schreiner A.

J Child Neurol. 2007 Mar;22(3):302-6.

PMID:
17621500
6.

West syndrome, can topiramate be on top?

Al-Baradie RS, Elseed MA.

Neurosciences (Riyadh). 2011 Jan;16(1):53-6.

PMID:
21206445
7.

A pilot study of topiramate in the treatment of infantile spasms.

Glauser TA, Clark PO, Strawsburg R.

Epilepsia. 1998 Dec;39(12):1324-8.

8.

A prospective study on the treatment of infantile spasms with first-line topiramate followed by low-dose ACTH.

Zhu X, Chen O, Zhang D, Jin R, Li F, Wang Y, Sun R.

Epilepsy Res. 2011 Feb;93(2-3):149-54. doi: 10.1016/j.eplepsyres.2010.12.002. Epub 2011 Jan 3.

PMID:
21205578
9.
10.

Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.

Grosso S, Franzoni E, Iannetti P, Incorpora G, Cardinali C, Toldo I, Verrotti A, Caterina Moscano F, Lo Faro V, Mazzone L, Zamponi N, Boniver C, Spalice A, Parisi P, Morgese G, Balestri P.

J Child Neurol. 2005 Nov;20(11):893-7.

PMID:
16417859
11.

Clinical experience with open-label topiramate use in infants younger than 2 years of age.

Watemberg N, Goldberg-Stern H, Ben-Zeev B, Berger I, Straussberg R, Kivity S, Kramer U, Brand N, Lerman-Sagie T.

J Child Neurol. 2003 Apr;18(4):258-62.

PMID:
12760428
12.

Efficacy and tolerability of topiramate in children younger than 2 years old.

Valencia I, Fons C, Kothare SV, Khurana DS, Yum S, Hardison HH, Legido A.

J Child Neurol. 2005 Aug;20(8):667-9.

PMID:
16225812
13.

Topiramate for drug-resistant epilepsies.

Yeung S, Ferrie CD, Murdoch-Eaton DG, Livingston JH.

Eur J Paediatr Neurol. 2000;4(1):31-3.

PMID:
10701102
14.

Prospective study of first-choice topiramate therapy in newly diagnosed infantile spasms.

Zou LP, Ding CH, Fang F, Sin NC, Mix E.

Clin Neuropharmacol. 2006 Nov-Dec;29(6):343-9.

PMID:
17095898
15.

Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.

Manitpisitkul P, Shalayda K, Todd M, Wang SS, Ness S, Ford L.

Epilepsia. 2013 Jan;54(1):156-64. doi: 10.1111/epi.12019. Epub 2012 Nov 13.

16.

Combined treatment with vigabatrin and topiramate in West syndrome.

Buoni S, Zannolli R, Strambi M, Fois A.

J Child Neurol. 2004 May;19(5):385-6.

PMID:
15224711
17.

[The use of topiramate in the treatment of focal epilepsy in children].

Kremenchugskaia MR, Globa OV, Kuzenkova LM.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(12):33-8. Russian.

PMID:
24430032
18.

Topiramate and adrenocorticotropic hormone (ACTH) as initial treatment for infantile spasms.

Peltzer B, Alonso WD, Porter BE.

J Child Neurol. 2009 Apr;24(4):400-5. doi: 10.1177/0883073808324538. Epub 2009 Feb 18.

19.

Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.

Guerrini R, Carpay J, Groselj J, van Oene J, Schreiner A, Lahaye M, Schwalen S; TOP-INT-51 Investigators' Group.

Seizure. 2005 Sep;14(6):371-80.

20.

Supplemental Content

Support Center